Data
Genomics
Solutions
Research
Resources
About
- Blog
- Members
- Leadership
- Events & webinars
- News
- Careers



Sign in

Close

Blog

In this study, Truveta Research explores patterns of GLP-1 RA medication switching from 2018 to 2023 and demographic characteristics of patients who switched.

ISPE 2024: Real-world patterns in GLP-1 RA switching from 2018-2023 in the US

August 22, 2024

Truveta on GeekWire top startup list

Truveta moves up on GeekWire’s Top 200 startup list

August 19, 2024

psoriasis and psoriatic arthritis in Truveta Data the most complete, timely, and clean EHR data

Advancing psoriasis research with regulatory-grade EHR data

August 15, 2024

How UnitedHealth turned a questionable artery-screening program into a gold mine

Truveta Research uses EHR data to explore medication switching trends from Humira to approved biosimilars following the CVS formulary changes

Exploring medication switching trends from Humira to approved biosimilars

ovarian cancer EHR data

Improving ovarian cancer outcomes with EHR data

Truveta CTO Jay Nanduri discusses Truveta's approach to healthcare AI and LLMs to make the richness of EHR data available for medical research.

Scaling AI models for growth

Truveta Research in collaboration with Ezekiel Emanuel, MD, PhD, explored trends and factors in the stopping and restarting of GLP-1 medications

Truveta Research leads first study to explore GLP-1 reinitiation trends and factors

« Previous
1
…
21
22
23
…
41
Next »

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Genome Project

© Truveta 2026

Our website uses cookies to ensure you have the best experience.